Maven Securities LTD Horizon Therapeutics Public LTD CO Transaction History

Maven Securities LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $24.6 Million - $28.8 Million	248,804 Added 611.31%	289,504 $33.5 Million
Q2 2023 Aug 04, 2023	SELL	$96.34 - $112.38 $13.3 Million - $15.5 Million	-137,678 Reduced 77.18%	40,700 $4.19 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $5.56 Million - $5.88 Million	-51,767 Reduced 22.49%	178,378 $19.5 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $14.4 Million - $26.2 Million	230,145 New	230,145 $26.2 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $7.18 Million - $9.55 Million	-100,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $5.83 Million - $7.34 Million	86,962 Added 666.99%	100,000 $7.32 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $720,088 - $1.04 Million	13,038 New	13,038 $1.01 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.